A ressonância magnética cardíaca (RMC) é uma técnica sem radiação, considerada padrão para avaliação da anatomia, função e até composição do tecido cardíaco. O estudo RESILIENCE usará a RMC como a principal metodologia para medir os resultados da intervenção e os doentes inscritos no estudo serão submetidos a três exames ao longo da duração do estudo.
Ensaio clínico multinacional, prospectivo, de prova de conceito, de fase II com dupla ocultação, controlado com simulação, aleatorizado (RCT) para avaliar a eficácia e segurança do Condicionamento Isquémico Remoto (RIC) em doentes com linfoma não Hodgkin (LNH) que são tratados com antraciclinas. Os doentes programados para receberem pelo menos 5 ciclos de quimioterapia com antraciclinas são elegíveis para participar no estudo.
It is a great satisfaction for us to announce the incorporation of the Amsterdam UMC Hospital to the RESILIENCE project on November 8th. Amsterdam UMC is one of the largest academic hospitals in the Netherlands and consists of 2 centers: The Amsterdam UMC located at the AMC (Academic Medical Center)
On October 23rd, Puerta de Hierro Majadahonda University Hospital joined the RESILIENCE project, so hopefully it will begin to incorporate patients into the trial in the coming days. This hospital was created in 1964 and, since then, it has fulfilled a triple function: care, teaching and research. Currently, as a
Cancer patients receiving anthracycline chemotherapy have more than twice the risk of developing heart failure compared to their peers without cancer. The ground-breaking RESILIENCE project aims to prevent heart failure in patients who need anthracyclines to treat their cancer. International experts and patients from the project gathered on October 19th
On Thursday, November 16th at 19:00 hours we will organize the “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” within the activities held in Madrid on the occasion of the Science and Innovation Week. The “RESILIENCE Workshop and laboratory visit. Surviving cancer with a strong heart” will consist of a free activity, for
During the Global Cardio Oncology Summit 2023, that took place in Madrid last September 27th, we had the opportunity of listening Dr. Borja Ibáñez, coordinator of RESILIENCE project and Scientific Director of CNIC, discussing with Dr. Bonnie Ky, Director of the Penn Center for Quantitative Echocardiography and Thalheimer Center for
The European Society of Cardiology (ESC) through the ESC Council of Cardio-Oncology will host on October 19th the first multi-stakeholder meeting in the context the RESILIENCE project, funded by the European Commission, to share the latest results with different stakeholders and patients. The event will focus on emerging therapies for
